{"id":9755,"date":"2026-05-04T12:53:07","date_gmt":"2026-05-04T17:53:07","guid":{"rendered":"https:\/\/fifarma.org\/?post_type=publicaciones&#038;p=9755"},"modified":"2026-05-04T12:53:08","modified_gmt":"2026-05-04T17:53:08","slug":"innovative-medicines-availability-wait-indicator-2026","status":"publish","type":"publicaciones","link":"https:\/\/fifarma.org\/pt\/publicaciones\/innovative-medicines-availability-wait-indicator-2026\/","title":{"rendered":"FIFARMA Patient W.A.I.T. Indicator 2026 \u2014 Latin America"},"content":{"rendered":"<p class=\"wp-block-paragraph\">This summary report, developed by <strong>FIFARMA<\/strong> in collaboration with IQVIA, presents the key findings of the Patient W.A.I.T. Indicator 2026 for Latin America, analyzing access to and availability of innovative medicines across ten countries in the region. This year\u2019s study includes 447 innovative molecules approved globally between 2014 and 2025, representing more than 80% of the new active substances approved worldwide during that period. The report provides an analysis of the availability and accessibility of innovative medicines in Latin America, as well as differences across healthcare systems. This preview corresponds to a summary, and the full study will be available soon.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><a href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2026\/05\/IQVIA_FIFARMA_WAIT-Root_Causes_2026_Summary.pdf\" type=\"link\" id=\"https:\/\/fifarma.org\/wp-content\/uploads\/2026\/05\/IQVIA_FIFARMA_WAIT-Root_Causes_2026_Summary.pdf\">View document<\/a><\/strong><\/p>\n\n    <div class=\"xs_social_share_widget xs_share_url after_content \t\tmain_content  wslu-style-1 wslu-share-box-shaped wslu-fill-colored wslu-none wslu-share-horizontal wslu-theme-font-no wslu-main_content\">\n\n\t\t\n        <ul>\n\t\t\t        <\/ul>\n    <\/div>","protected":false},"author":26,"parent":0,"template":"","ano":[187],"idioma":[45],"etiquetas-publicacion":[],"categoria-publicacion":[],"class_list":["post-9755","publicaciones","type-publicaciones","status-publish","hentry","ano-187","idioma-english"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.7 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Innovative medicines availability: Patient W.A.I.T. Indicator 2026<\/title>\n<meta name=\"description\" content=\"Read the FIFARMA Patient W.A.I.T. Indicator 2026 summary. Analysis of innovative medicines availability across 10 Latin American countries and 447 molecules.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fifarma.org\/pt\/publicacoes\/innovative-medicines-availability-wait-indicator-2026\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FIFARMA Patient W.A.I.T. Indicator 2026 \u2014 Latin America\" \/>\n<meta property=\"og:description\" content=\"Read the FIFARMA Patient W.A.I.T. Indicator 2026 summary. Analysis of innovative medicines availability across 10 Latin American countries and 447 molecules.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fifarma.org\/pt\/publicacoes\/innovative-medicines-availability-wait-indicator-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"FIFARMA\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-04T17:53:08+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/innovative-medicines-availability-wait-indicator-2026\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/innovative-medicines-availability-wait-indicator-2026\\\/\",\"name\":\"Innovative medicines availability: Patient W.A.I.T. Indicator 2026\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\"},\"datePublished\":\"2026-05-04T17:53:07+00:00\",\"dateModified\":\"2026-05-04T17:53:08+00:00\",\"description\":\"Read the FIFARMA Patient W.A.I.T. Indicator 2026 summary. Analysis of innovative medicines availability across 10 Latin American countries and 447 molecules.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/innovative-medicines-availability-wait-indicator-2026\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/innovative-medicines-availability-wait-indicator-2026\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/innovative-medicines-availability-wait-indicator-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/fifarma.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publicaciones\",\"item\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"FIFARMA Patient W.A.I.T. Indicator 2026 \u2014 Latin America\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"name\":\"FIFARMA\",\"description\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fifarma.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\",\"name\":\"Fifarma\",\"alternateName\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"width\":195,\"height\":39,\"caption\":\"Fifarma\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Innovative medicines availability: Patient W.A.I.T. Indicator 2026","description":"Read the FIFARMA Patient W.A.I.T. Indicator 2026 summary. Analysis of innovative medicines availability across 10 Latin American countries and 447 molecules.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fifarma.org\/pt\/publicacoes\/innovative-medicines-availability-wait-indicator-2026\/","og_locale":"pt_BR","og_type":"article","og_title":"FIFARMA Patient W.A.I.T. Indicator 2026 \u2014 Latin America","og_description":"Read the FIFARMA Patient W.A.I.T. Indicator 2026 summary. Analysis of innovative medicines availability across 10 Latin American countries and 447 molecules.","og_url":"https:\/\/fifarma.org\/pt\/publicacoes\/innovative-medicines-availability-wait-indicator-2026\/","og_site_name":"FIFARMA","article_modified_time":"2026-05-04T17:53:08+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fifarma.org\/publicaciones\/innovative-medicines-availability-wait-indicator-2026\/","url":"https:\/\/fifarma.org\/publicaciones\/innovative-medicines-availability-wait-indicator-2026\/","name":"Innovative medicines availability: Patient W.A.I.T. Indicator 2026","isPartOf":{"@id":"https:\/\/fifarma.org\/#website"},"datePublished":"2026-05-04T17:53:07+00:00","dateModified":"2026-05-04T17:53:08+00:00","description":"Read the FIFARMA Patient W.A.I.T. Indicator 2026 summary. Analysis of innovative medicines availability across 10 Latin American countries and 447 molecules.","breadcrumb":{"@id":"https:\/\/fifarma.org\/publicaciones\/innovative-medicines-availability-wait-indicator-2026\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fifarma.org\/publicaciones\/innovative-medicines-availability-wait-indicator-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fifarma.org\/publicaciones\/innovative-medicines-availability-wait-indicator-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fifarma.org\/"},{"@type":"ListItem","position":2,"name":"Publicaciones","item":"https:\/\/fifarma.org\/publicaciones\/"},{"@type":"ListItem","position":3,"name":"FIFARMA Patient W.A.I.T. Indicator 2026 \u2014 Latin America"}]},{"@type":"WebSite","@id":"https:\/\/fifarma.org\/#website","url":"https:\/\/fifarma.org\/","name":"FIFARMA","description":"Federa\u00e7\u00e3o Latino-Americana da Ind\u00fastria Farmac\u00eautica","publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fifarma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/fifarma.org\/#organization","name":"Fifarma","alternateName":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","url":"https:\/\/fifarma.org\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","width":195,"height":39,"caption":"Fifarma"},"image":{"@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/publicaciones\/9755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/publicaciones"}],"about":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/types\/publicaciones"}],"author":[{"embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/users\/26"}],"wp:attachment":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/media?parent=9755"}],"wp:term":[{"taxonomy":"ano","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/ano?post=9755"},{"taxonomy":"idioma","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/idioma?post=9755"},{"taxonomy":"etiquetas-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/etiquetas-publicacion?post=9755"},{"taxonomy":"categoria-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/categoria-publicacion?post=9755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}